IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.0082
+0.0017 (26.15%)
At close: Jun 5, 2026
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $589.98 thousand as of June 8, 2026. Its market cap has decreased by -99.25% in one year.
Market Cap
589.98K
Enterprise Value
-11.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 8, 2021, IO Biotech's market cap has decreased from 364.82M to 589.98K, a decrease of -99.84%. That is a compound annual growth rate of -75.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 611.57K | -98.60% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -49.45% |
| Nov 8, 2021 | 364.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 841.41K |
| Halberd | 747.30K |
| Emmaus Life Sciences | 715.92K |
| SQZ Biotechnologies Company | 707.79K |
| Windtree Therapeutics | 647.83K |
| CERo Therapeutics Holdings | 572.48K |
| THC Farmaceuticals | 563.89K |
| Lipella Pharmaceuticals | 485.19K |